Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies

NCT00776373 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

ALL
Burkitt's Lymphoma
Lymphoblastic Leukemia
CML

Interventions

DRUG: Rapamycin
DRUG: High dose etoposide and cytarabine (HiVAC)

Sponsor

Abramson Cancer Center at Penn Medicine